Edwards Lifesciences Corporation
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionCommonwealth Equity Services, Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Commonwealth Equity Services, Llc closes position in EW / Edwards Lifesciences Corporation

On April 27, 2026 - Commonwealth Equity Services, Llc filed a 13F-HR form disclosing ownership of 0 shares of Edwards Lifesciences Corporation (MX:EW) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 119,083 shares of Edwards Lifesciences Corporation. This represents a change in shares of -100.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 0 -119,083 -100.00 0 -100.00
2026-02-12 2025-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 119,083 -9,270 -7.22 10,152 112,688.89 0.0135
2025-10-22 2025-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 128,353 -4,896 -3.67 10 -10.00 0.0129
2025-08-06 2025-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 133,249 -30,752 -18.75 10 -9.09 0.0138
2025-05-09 2025-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 164,001 443 0.27 12 -8.33 0.0168
2025-02-10 2024-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 163,558 -29,569 -15.31 12 0.00 0.0177
2024-10-18 2024-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 193,127 -20,494 -9.59 13 -36.84 0.0193
2024-07-31 2024-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 213,621 32,358 17.85 20 11.76 0.0312
2024-04-29 2024-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 181,263 42,744 30.86 17 70.00 0.0288
2024-02-06 2023-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 138,519 -25,465 -15.53 11 -9.09 0.0193
2023-10-23 2023-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 163,984 11,117 7.27 11 -21.43 0.0235
2023-08-10 2023-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 152,867 18,113 13.44 14 27.27 0.0293
2023-05-11 2023-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 134,754 12,683 10.39 11 22.22 0.0234
2023-02-07 2022-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 122,071 -16,231 -11.74 9 -99.92 0.0219
2022-11-14 2022-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 138,302 2,579 1.90 11,427 -11.45 0.0294
2022-07-19 2022-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 135,723 1,396 1.04 12,905 -18.39 0.0336
2022-05-04 2022-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 134,327 5,885 4.58 15,813 -4.96 0.0362
2022-01-31 2021-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 128,442 45 0.04 16,639 14.48 0.0375
2021-10-29 2021-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 128,397 -2,020 -1.55 14,535 7.61 0.0365
2021-08-11 2021-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 130,417 6,957 5.64 13,507 30.81 0.0343
2021-05-04 2021-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 123,460 -4,201 -3.29 10,326 -11.33 0.0292
2021-02-11 2020-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 127,661 -4,328 -3.28 11,646 10.55 0.0350
2020-11-05 2020-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 131,989 -1,520 -1.14 10,535 14.19 0.0360
2020-08-12 2020-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 133,509 95,901 255.00 9,226 30.07 0.0348
2020-05-11 2020-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 37,608 -4,891 -11.51 7,093 -28.45 0.0330
2020-02-05 2019-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 42,499 1,272 3.09 9,914 9.35 0.0377
2019-10-30 2019-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 41,227 4,522 12.32 9,066 33.72 0.0387
2019-07-19 2019-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 36,705 7 0.02 6,780 -3.43 0.0299
2019-05-13 2019-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 36,698 8,544 30.35 7,021 62.82 0.0324
2019-02-11 2018-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 28,154 1,391 5.20 4,312 -7.45 0.0229
2018-11-06 2018-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 26,763 1,335 5.25 4,659 25.85 0.0223
2018-07-31 2018-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 25,428 -971 -3.68 3,702 0.52 0.0194
2018-05-14 2018-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 26,399 2,816 11.94 3,683 38.56 0.0200
2018-02-12 2017-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 23,583 23,583 2,658 0.0145
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.